Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-03-04 Sale |
2022-03-08 4:05 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Drape Eric Executive VP Global Operations |
34,792 | $7.4448 | $259,019 | 291,788 (Direct) |
View |
| 2022-03-04 Sale |
2022-03-08 4:04 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Dethlefs Sven EVP, North America Commercial |
10,897 | $7.4082 | $80,727 | 408,324 (Direct) |
View |
| 2022-03-04 Sale |
2022-03-08 4:03 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
58,952 | $7.4382 | $438,494 | 260,879 (Direct) |
View |
| 2022-02-28 Sale |
2022-03-02 07:54 am |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Stark David Matthew Exec. VP Chief Legal Officer |
6,452 | $8.1422 | $52,533 | 58,240 (Direct) |
View |
| 2022-02-28 Sale |
2022-03-02 07:53 am |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Shani Eli EVP,Global Marketing&Portfolio |
5,311 | $8.1422 | $43,243 | 19,714 (Direct) |
View |
| 2022-02-28 Sale |
2022-03-02 07:47 am |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D |
7,590 | $8.1422 | $61,799 | 108,875 (Direct) |
View |
| 2022-02-28 Sale |
2022-03-02 07:45 am |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Drape Eric Executive VP Global Operations |
9,797 | $8.1422 | $79,769 | 84,859 (Direct) |
View |
| 2022-02-28 Sale |
2022-03-02 07:43 am |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Dethlefs Sven EVP, North America Commercial |
4,862 | $8.1422 | $39,587 | 134,149 (Direct) |
View |
| 2022-02-28 Sale |
2022-03-02 07:41 am |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
20,598 | $8.1422 | $167,713 | 61,477 (Direct) |
View |
| 2022-02-09 Sale |
2022-02-10 4:13 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Stark David Matthew Exec. VP Chief Legal Officer |
6,110 | $9.0602 | $55,358 | 47,341 (Direct) |
View |
| 2022-02-09 Sale |
2022-02-10 4:09 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D |
6,116 | $9.0602 | $55,412 | 102,905 (Direct) |
View |
| 2022-02-09 Sale |
2022-02-10 4:08 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Drape Eric Executive VP Global Operations |
3,583 | $9.0605 | $32,464 | 68,631 (Direct) |
View |
| 2022-02-09 Sale |
2022-02-10 4:06 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Dethlefs Sven EVP, North America Commercial |
4,138 | $9.0602 | $37,491 | 124,912 (Direct) |
View |
| 2022-02-09 Sale |
2022-02-10 4:05 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
13,135 | $9.0605 | $119,010 | 63,638 (Direct) |
View |
| 2021-08-10 Sale |
2021-08-12 4:04 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D |
50,860 | $9.9493 | $506,021 | 41,412 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-03-04 Exercise |
2022-03-08 4:05 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Drape Eric Executive VP Global Operations |
67,034 | $0 | 291,788 (Direct) |
View |
| 2022-03-04 Option Award |
2022-03-08 4:05 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Drape Eric Executive VP Global Operations |
134,048 | $0 | 291,788 (Direct) |
View |
| 2022-03-04 Exercise |
2022-03-08 4:04 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Dethlefs Sven EVP, North America Commercial |
76,821 | $0 | 408,324 (Direct) |
View |
| 2022-03-04 Option Award |
2022-03-08 4:04 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Dethlefs Sven EVP, North America Commercial |
154,155 | $0 | 408,324 (Direct) |
View |
| 2022-03-04 Exercise |
2022-03-08 4:03 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
81,854 | $0 | 260,879 (Direct) |
View |
| 2022-03-04 Option Award |
2022-03-08 4:03 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
134,048 | $0 | 260,879 (Direct) |
View |
| 2022-02-28 Exercise |
2022-03-02 07:55 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Weiss Amir Chief Accounting Officer |
4,200 | $0 | 25,029 (Direct) |
View |
| 2022-02-28 Exercise |
2022-03-02 07:54 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Stark David Matthew Exec. VP Chief Legal Officer |
18,430 | $0 | 58,240 (Direct) |
View |
| 2022-02-28 Exercise |
2022-03-02 07:53 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Shani Eli EVP,Global Marketing&Portfolio |
5,311 | $0 | 19,714 (Direct) |
View |
| 2022-02-28 Exercise |
2022-03-02 07:51 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Schultz Kare President and CEO |
65,047 | $0 | 1,262,592 (Direct) |
View |
| 2022-02-28 Exercise |
2022-03-02 07:50 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Sabag Mark EVP, International Markets |
20,598 | $0 | 135,800 (Direct) |
View |
| 2022-02-28 Exercise |
2022-03-02 07:49 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Kalif Eliyahu Sharon EVP, Chief Financial Officer |
18,430 | $0 | 80,349 (Direct) |
View |
| 2022-02-28 Exercise |
2022-03-02 07:48 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Inbar Galia See "Remarks" |
4,828 | $0 | 19,313 (Direct) |
View |
| 2022-02-28 Exercise |
2022-03-02 07:47 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D |
21,682 | $0 | 108,875 (Direct) |
View |
| 2022-02-28 Exercise |
2022-03-02 07:45 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Drape Eric Executive VP Global Operations |
19,514 | $0 | 84,859 (Direct) |
View |
| 2022-02-28 Exercise |
2022-03-02 07:43 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Dethlefs Sven EVP, North America Commercial |
17,346 | $0 | 134,149 (Direct) |
View |
| 2022-02-28 Exercise |
2022-03-02 07:41 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
20,598 | $0 | 61,477 (Direct) |
View |
| 2022-02-13 Exercise |
2022-02-15 07:28 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Kalif Eliyahu Sharon EVP, Chief Financial Officer |
6,629 | $0 | 38,318 (Direct) |
View |
| 2021-11-19 Ownership |
2022-02-10 4:15 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Zaks Tal Zvi Director |
17 | $8.88 | 17 (Direct) |
View |
| 2022-02-09 Exercise |
2022-02-10 4:13 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Stark David Matthew Exec. VP Chief Legal Officer |
12,538 | $0 | 47,341 (Direct) |
View |
| 2022-02-08 Option Award |
2022-02-10 4:13 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Stark David Matthew Exec. VP Chief Legal Officer |
37,939 | $0 | 47,341 (Direct) |
View |
| 2022-02-09 Exercise |
2022-02-10 4:12 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Schultz Kare President and CEO |
26,867 | $0 | 1,230,042 (Direct) |
View |
| 2022-02-08 Option Award |
2022-02-10 4:12 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Schultz Kare President and CEO |
162,593 | $0 | 1,230,042 (Direct) |
View |
| 2022-02-09 Exercise |
2022-02-10 4:10 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Sabag Mark EVP, International Markets |
15,523 | $0 | 117,363 (Direct) |
View |
| 2022-02-08 Option Award |
2022-02-10 4:10 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Sabag Mark EVP, International Markets |
43,358 | $0 | 117,363 (Direct) |
View |
| 2022-02-09 Exercise |
2022-02-10 4:09 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D |
16,121 | $0 | 102,905 (Direct) |
View |
| 2022-02-08 Option Award |
2022-02-10 4:09 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fridriksdottir Hafrun Executive VP, Global R&D |
51,488 | $0 | 102,905 (Direct) |
View |
| 2022-02-09 Exercise |
2022-02-10 4:08 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Drape Eric Executive VP Global Operations |
6,568 | $0 | 68,631 (Direct) |
View |
| 2022-02-08 Option Award |
2022-02-10 4:08 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Drape Eric Executive VP Global Operations |
32,518 | $0 | 68,631 (Direct) |
View |
| 2022-02-09 Exercise |
2022-02-10 4:06 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Dethlefs Sven EVP, North America Commercial |
13,135 | $0 | 124,912 (Direct) |
View |
| 2022-02-08 Option Award |
2022-02-10 4:06 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Dethlefs Sven EVP, North America Commercial |
37,939 | $0 | 124,912 (Direct) |
View |
| 2022-02-09 Exercise |
2022-02-10 4:05 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
13,135 | $0 | 63,638 (Direct) |
View |
| 2022-02-08 Option Award |
2022-02-10 4:05 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
43,358 | $0 | 63,638 (Direct) |
View |
Ownership |
2021-12-06 09:42 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Weiss Amir Chief Accounting Officer |
0 | $0 | 72,109 (Direct) |
View |
| 2021-11-04 Option Award |
2021-11-08 4:02 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Zaks Tal Zvi Director |
12,205 | $0 | 12,205 (Direct) |
View |
| 2021-11-02 Option Award |
2021-11-04 07:27 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Weil Andrew Chief Accounting Officer |
29,673 | $0 | 29,673 (Direct) |
View |
| 2021-11-01 Exercise |
2021-11-03 07:25 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Schultz Kare President and CEO |
180,000 | $0 | 1,156,971 (Direct) |
View |
Ownership |
2021-08-19 4:03 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Shani Eli EVP,Global Marketing&Portfolio |
0 | $0 | 135,141 (Direct) |
View |
Ownership |
2021-08-19 4:02 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Inbar Galia See "Remarks" |
0 | $0 | 47,860 (Direct) |
View |
| 2021-06-14 Option Award |
2021-06-16 08:23 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Vergis Janet S. Director |
14,479 | $0 | 14,479 (Direct) |
View |
| 2021-06-09 Acquisition |
2021-06-16 08:22 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Satchi-Fainaro Ronit Director |
550 | $0 | 51,359 (Direct) |
View |
| 2021-06-14 Option Award |
2021-06-16 08:22 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Satchi-Fainaro Ronit Director |
14,479 | $0 | 51,359 (Direct) |
View |
| 2021-06-14 Option Award |
2021-06-16 08:21 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Peres Nechemia Jacob Director |
14,479 | $0 | 14,479 (Direct) |
View |
| 2021-06-14 Option Award |
2021-06-16 08:20 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Nisen Perry Director |
14,479 | $0 | 14,479 (Direct) |
View |
| 2021-06-14 Option Award |
2021-06-16 08:20 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | MIGNONE ROBERTO Director |
14,479 | $0 | 14,479 (Direct) |
View |
| 2021-06-14 Option Award |
2021-06-16 08:19 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | LIEBERMAN GERALD M Director |
14,479 | $0 | 14,479 (Direct) |
View |
| 2021-06-14 Option Award |
2021-06-16 08:18 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Hussain Abbas Director |
14,479 | $0 | 14,479 (Direct) |
View |
| 2021-06-14 Option Award |
2021-06-16 08:15 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Halfon Jean Michel Director |
14,479 | $0 | 14,479 (Direct) |
View |
| 2021-06-14 Option Award |
2021-06-16 08:13 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Elstein Amir Director |
14,479 | $0 | 14,479 (Direct) |
View |